Vamorolone Treatment of Duchenne Muscular Dystrophy Patients Leads to Improvements in Motor Function

Rockville, MD –  18 August 2019
A publication in the journal Neurology was released today describing efficacy studies of vamorolone, a treatment option being evaluated as a potentially safer alternative to corticosteroids, in boys with Duchenne muscular dystrophy.